John D. Cook - Search Results

Year	Number of Results
2004	2
2006	3
2008	3
2009	1
2013	1
2017	1
2018	1
2024	0

1

Dose-finding based on efficacy-toxicity trade-offs.

Thall PF, Cook JD. Thall PF, et al. Among authors: cook jd. Biometrics. 2004 Sep;60(3):684-93. doi: 10.1111/j.0006-341X.2004.00218.x. Biometrics. 2004. PMID: 15339291

2

Comparing three regularization methods to avoid extreme allocation probability in response-adaptive randomization.

Du Y, Cook JD, Lee JJ. Du Y, et al. Among authors: cook jd. J Biopharm Stat. 2018;28(2):309-319. doi: 10.1080/10543406.2017.1293077. Epub 2017 Mar 21. J Biopharm Stat. 2018. PMID: 28323532 Free PMC article.

3

Accounting for patient heterogeneity in phase II clinical trials.

Wathen JK, Thall PF, Cook JD, Estey EH. Wathen JK, et al. Among authors: cook jd. Stat Med. 2008 Jul 10;27(15):2802-15. doi: 10.1002/sim.3109. Stat Med. 2008. PMID: 17948869 Free PMC article.

4

Adaptive dose selection using efficacy-toxicity trade-offs: illustrations and practical considerations.

Thall PF, Cook JD, Estey EH. Thall PF, et al. Among authors: cook jd. J Biopharm Stat. 2006;16(5):623-38. doi: 10.1080/10543400600860394. J Biopharm Stat. 2006. PMID: 17037262

5

Calcium transients regulate patterned actin assembly during myofibrillogenesis.

Li H, Cook JD, Terry M, Spitzer NC, Ferrari MB. Li H, et al. Among authors: cook jd. Dev Dyn. 2004 Feb;229(2):231-42. doi: 10.1002/dvdy.10428. Dev Dyn. 2004. PMID: 14745949 Free article.

6

Stochastic inequality probabilities for adaptively randomized clinical trials.

Cook JD, Nadarajah S. Cook JD, et al. Biom J. 2006 Jun;48(3):356-65. doi: 10.1002/bimj.200510220. Biom J. 2006. PMID: 16845901

7

PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer.

Herzog A, Bian Y, Vander Broek R, Hall B, Coupar J, Cheng H, Sowers AL, Cook JD, Mitchell JB, Chen Z, Kulkarni AB, Van Waes C. Herzog A, et al. Among authors: cook jd. Clin Cancer Res. 2013 Jul 15;19(14):3808-19. doi: 10.1158/1078-0432.CCR-12-2716. Epub 2013 May 2. Clin Cancer Res. 2013. PMID: 23640975 Free PMC article.

8

Practical model-based dose finding in early-phase clinical trials: optimizing tissue plasminogen activator dose for treatment of ischemic stroke in children.

Whelan HT, Cook JD, Amlie-Lefond CM, Hovinga CA, Chan AK, Ichord RN, Deveber GA, Thall PF. Whelan HT, et al. Among authors: cook jd. Stroke. 2008 Sep;39(9):2627-36. doi: 10.1161/STROKEAHA.107.510164. Epub 2008 Jul 10. Stroke. 2008. PMID: 18617665

9

Exercise training produces nonuniform increases in arteriolar density of rat soleus and gastrocnemius muscle.

Laughlin MH, Cook JD, Tremble R, Ingram D, Colleran PN, Turk JR. Laughlin MH, et al. Microcirculation. 2006 Apr-May;13(3):175-86. doi: 10.1080/10739680600556829. Microcirculation. 2006. PMID: 16627360 Free PMC article.

10

Bayesian design of single-arm phase II clinical trials with continuous monitoring.

Johnson VE, Cook JD. Johnson VE, et al. Among authors: cook jd. Clin Trials. 2009 Jun;6(3):217-26. doi: 10.1177/1740774509105221. Clin Trials. 2009. PMID: 19528131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year